Jin Medical International (NASDAQ:ZJYL) & Heart Test Laboratories (NASDAQ:HSCS) Head-To-Head Comparison

Heart Test Laboratories (NASDAQ:HSCS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.

Insider & Institutional Ownership

17.2% of Heart Test Laboratories shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Heart Test Laboratories and Jin Medical International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heart Test Laboratories	N/A	-144.12%	-94.48%
Jin Medical International	N/A	N/A	N/A

Risk & Volatility

Heart Test Laboratories has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 13.67, meaning that its share price is 1,267% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for Heart Test Laboratories and Jin Medical International, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Test Laboratories	0	0	2	0	3.00
Jin Medical International	0	0	0	0	0.00

Heart Test Laboratories presently has a consensus target price of $13.50, suggesting a potential upside of 253.40%. Given Heart Test Laboratories’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Heart Test Laboratories is more favorable than Jin Medical International.

Earnings and Valuation

This table compares Heart Test Laboratories and Jin Medical International”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Test Laboratories	$20,000.00	173.81	-$6.61 million	($21.64)	-0.18
Jin Medical International	$20.13 million	5.99	$2.88 million	N/A	N/A

Jin Medical International has higher revenue and earnings than Heart Test Laboratories.

Summary

Heart Test Laboratories beats Jin Medical International on 6 of the 11 factors compared between the two stocks.

About Heart Test Laboratories

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

About Jin Medical International

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.